Teva's Mylan stake raises concerns for defense foundation; Cardinal Health paying $1.1B for generics distributor;

@FiercePharma: FDA launches safety investigation of controversial raw foods for pets. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: FDA warning letter says Czech company shipped bacteria contaminated APIs to the U.S. More | Follow @EricPFierce

@CarlyHFierce: AbbVie, J&J gallop toward first-line Imbruvica sales with new survival data. FiercePharma report | Follow @CarlyHFierce

> A foundation that could help block a takeover of Mylan ($MYL) says it has concerns regarding the stake in the drugmaker that suitor Teva ($TEVA) recently picked up. More

> Drug distributor Cardinal Health ($CAH) will pay $1.1 billion to buy generic drug distributor The Harvard Drug Group. Report

> Blenheim Pharmacal is recalling 166 bottles of captopril tablets manufactured by India's Wockhardt after the FDA noted cGMP deviations that Wockhardt had not fully investigated customer complaints. Notice

Medical Device News

@FierceMedDev: Exact Sciences joins forces with MD Anderson for lung cancer Dx development. More from FierceDiagnostics | Follow @FierceMedDev

@VarunSaxena2: Journalists who were jailed by the feds call for federal shield law | National Press Club. More | Follow @VarunSaxena2

@EmilyWFierce: OPKO scoops up Bio-Reference Laboratories for $1.47B. News | Follow @EmilyWFierce

> China's Mindray Medical weighing offer from management to take company private. Story

> Medtronic aims for diabetic consumer tech in deals with Samsung, Glooko and connected MiniMed clearance. Article

Biotech News

@FierceBiotech: FDA says Sanofi and Regeneron's cardio contender looks approvable. But for whom? More | Follow @FierceBiotech

@JohnCFierce: ICYMI: Vertex beefs up its cystic fibrosis pipeline with $1.2B Parion R&D pact. Article | Follow @JohnCFierce

@DamianFierce: Next week's PCSK9 adcomms are at the "Hilton Washington DC/Gaithersburg," which is like saying "Marriott U.S./Greenland." | Follow @DamianFierce

> Abivax tees up a $49M IPO to get its hep B shot into Phase III. Story

> NIH slams the brakes on drug production after contamination scare. Report

And Finally... A new test can reveal nearly every virus a person has ever been exposed to using less than a drop of blood, researchers have found. More (sub. req.)

Suggested Articles

Download our solutions overview to discover how CoverMyMeds can make a difference for your brand.

In a bladder cancer field chock-full of checkpoint inhibitors, Pfizer and Merck KGaA’s Bavencio has a chance to get ahead thanks to new data.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.